A high-content screening assay for small-molecule modulators of oncogene-induced senescence

Benjamin G Bitler1, Lauren S Fink, Zhi Wei

  • 11Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA, USA.

Insights

Researchers identified key protein kinases involved in oncogene-induced senescence (OIS) using a novel screening platform. This discovery aids in understanding tumor suppression mechanisms and developing targeted cancer therapies.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Cellular senescence is a critical tumor suppression mechanism.
  • Oncogene-induced senescence (OIS) prevents cell transformation but its signaling pathways are not fully understood.
  • Protein kinases are frequently involved in oncogene-induced signaling.

Purpose of the Study:

  • To identify target proteins crucial for RAS-induced senescence.
  • To develop and utilize a high-content screening platform for OIS research.

Main Methods:

  • A small-molecule kinase inhibitor screen was performed on primary human fibroblasts.
  • Senescence was induced by oncogenic RAS (H-Ras(G12V)).
  • High-content imaging assessed senescence-associated β-galactosidase activity, proliferation inhibition, and heterochromatin foci.

Main Results:

  • A novel high-content screening platform for studying OIS was established.
  • Several small-molecule kinase inhibitors that suppress RAS-induced senescence were identified.
  • Validated compounds confirmed critical pathway components involved in OIS.

Conclusions:

  • The developed screening platform is effective for elucidating OIS signaling pathways.
  • Targeting identified protein kinases may offer therapeutic strategies against cancer.
  • Further research can leverage this platform to uncover novel OIS regulators.